Effects of E4/DRSP on self-reported physical and emotional premenstrual and menstrual symptoms: data from the phase 3 clinical trial in Europe and Russia-Reference-Cited by-同舟云学术

Effects of E4/DRSP on self-reported physical and emotional premenstrual and menstrual symptoms: data from the phase 3 clinical trial in Europe and Russia

Published:2024-06-21 Issue:4 Volume:29 Page:150-159
ISSN:1362-5187
Container-title:The European Journal of Contraception & Reproductive Health Care
language:en
Short-container-title:The European Journal of Contraception & Reproductive Health Care

Author:

Bitzer Johannes¹,Bouchard Céline²,Zatik János³,Weyers Steven⁴,Piltonen Terhi⁵,Suturina Larisa⁶,Apolikhina Inna⁷,Gemzell-Danielsson Kristina⁸,Jost Maud⁹,Creinin Mitchell D.¹⁰,Foidart Jean-Michel¹¹

Affiliation:

1. Department of Obstetrics and Gynaecology, University Hospital of Basel, Basel, Switzerland

2. Clinique de Recherche en Santé des Femmes, Québec, Canada

3. Szent Anna Szuleszeti, Nogyogyaszati es Ultrahang Maganrendelo, Debrecen, Hungary

4. Department of Obstetrics and Gynaecology, Ghent University Hospital, Ghent, Belgium

5. Obstetrics and Gynecology, PEDEGO Research Unit, Medical Research Centre, Oulu University Hospital, Oulu, Finland

6. Department of Reproductive Health Protection, Scientific Center for Family Health and Human Reproduction, Irkutsk, Russian Federation

7. National Medical Research Center for Obstetrics, Gynaecology and Perinatology named after Academician V.I. Kulakov, Ministry of Healthcare of Russia, Moscow, Russia

8. Department of Women’s and Children’s Health, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden

9. Estetra SRL, an affiliate company of Mithra Pharmaceuticals, Liège, Belgium

10. Department of Obstetrics and Gynecology, University of CA, Sacramento, California, USA

11. Department of Gynaecology and Obstetrics, University of Liège, Liège, Belgium

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13625187.2024.2359117

Reference44 articles.

1. Women’s preferences for menstrual bleeding frequency: results of the Inconvenience Due to Women’s Monthly Bleeding (ISY) survey

2. Women’s values in contraceptive choice: a systematic review of relevant attributes included in decision aids

3. Examining the association between menstrual symptoms and health-related quality of life among working women in Japan using the EQ-5D

4. Estetrol is a weak estrogen antagonizing estradiol-dependent mammary gland proliferation

5. Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control